Current
0.29 €
+10.69% today
Start price
10.03 €
Target price
4.00 €
+27.5% to target
End price
5.52 €
Performance (%)
-45.01%
Return to target
+27.5%
Confidence
50%
Time horizon
2021-12-12
Performance since start
How it ranks
- #3 Rank 3 of 5 by performance
- 2 ratings for this instrument performed better
- No other running rating for this instrument right now
Summary
This prediction ended on 26.06.21 with a price of €5.52. nvestor correctly predicted massive losses of -45.01% for Envveno Medical Corp.. nvestor has 50% into this prediction
Investment thesis
Pros and cons by nvestor
For
Against
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
overvalued
Timeline & discussion
Reasoning and updates for this rating
The discussion is visible to sharewise members.
1 comment is waiting for you.